Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

Low vitamin D levels are linked to Alopecia Areata.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Lower adiponectin and higher leptin levels may predict hair loss in alopecia areata.

Baricitinib may help people with long-term alopecia areata.

Patients with Alopecia Areata have higher levels of certain inflammatory markers.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

People with severe hair loss have lower zinc levels in their blood.

There is a lack of quality online psychological support for alopecia areata patients.

High retinol intake may worsen hair loss in alopecia areata.

Patients with Alopecia Areata have lower levels of zinc and biotin than healthy individuals.

Higher IL-19 levels are linked to more severe Alopecia Areata.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

People with autism are more likely to develop alopecia areata than those without autism.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Monthly oral corticosteroid pulses effectively treat widespread alopecia areata in young patients.

Intralesional steroids are the most effective treatment for alopecia areata.

Oxidative stress may play a role in causing alopecia areata.

Ustekinumab helped three kids with alopecia areata regrow hair.

Patients with alopecia areata have lower RBC folate levels, especially in severe cases.

Almost half of the men with beard hair loss also developed scalp hair loss within a year.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Certain blood miRNAs are linked to severe alopecia areata and could lead to new treatments.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

Alopecia areata and atopic dermatitis have similar healthcare costs, but alopecia areata leads to more outpatient and long-term disability expenses.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Higher HDAC1 levels in alopecia areata suggest HDAC inhibitors might help treat it and acne.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.